Who owns the BELVIQ ER trademark?

The BELVIQ ER trademark is owned by Arena Pharmaceuticals GmbH.

What class is the BELVIQ ER trademark registered in?

The BELVIQ ER trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for BELVIQ ER?

The USPTO serial number for BELVIQ ER is 86330788.

What is the registration number for BELVIQ ER?

BELVIQ ER is registered under USPTO registration number 4699007.

Sealvo

Home Search: BELVIQ ERBELVIQ ER #86330788

Back

Updated Oct 17, 2026·33 searches this week

View on USPTO TSDR Find similar marks

BEL

USPTO Trademark Record

ABANDONED

BELVIQ ER

SN 86330788·Reg 4699007·Filed Jul 08, 2014

Owner Arena Pharmaceuticals GmbH

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

BELVIQ ER (Serial No. 86330788), Registration No. 4699007, is a abandoned US trademark filed on Jul 08, 2014 by Arena Pharmaceuticals GmbH. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

BELVIQ ER (Reg. #4699007) is an abandoned US trademark that was filed in 2014 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 08, 2014

SERIAL

86330788

REG#

4699007

REGISTERED

Mar 10, 2015

Filing Information

StatusABANDONED

Filing DateJul 08, 2014

Serial Number86330788

Registration No.4699007

Registration DateMar 10, 2015

Status DateDec 03, 2021

Published for OppositionDec 23, 2014

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

21 events

CANCELLED SEC. 8 (6-YR)

Dec 03, 2021

CANCELLED SEC. 8 (6-YR)

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Mar 10, 2020

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

Apr 05, 2017

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 31, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

REGISTERED-PRINCIPAL REGISTER

Mar 10, 2015

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Dec 23, 2014

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 23, 2014

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 03, 2014

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 17, 2014

APPROVED FOR PUB - PRINCIPAL REGISTER

LAW OFFICE PUBLICATION REVIEW COMPLETED

Nov 17, 2014

LAW OFFICE PUBLICATION REVIEW COMPLETED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 14, 2014

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 14, 2014

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Nov 07, 2014

ASSIGNED TO LIE

Oct 31, 2014

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 30, 2014

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Oct 22, 2014

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 22, 2014

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 22, 2014

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 20, 2014

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Jul 11, 2014

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 11, 2014

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Arena Pharmaceuticals GmbH

Additional USPTO filings from the same owner.

BEL

BELVIQ XR

86693911

Arena Pharmaceuticals GmbH

ABANDONED

LOR

LORQESS

86677907

Arena Pharmaceuticals GmbH

ABANDONED

SIL

SILLETO

86677915

Arena Pharmaceuticals GmbH

ABANDONED

BEL

BELVIQ SR

86330795

Arena Pharmaceuticals GmbH

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

79204953

Boehringer Ingelheim Vetmedica GmbH

REGISTERED

86588342

Essential Remedium Corp.

REGISTERED

HYS

HYSINGLA ER

86242700

KNOA PHARMA LLC

REGISTERED

SEP

SEPSET ER

97145614

Sepset Biosciences Inc.

REGISTERED

BELVIQ ER

Run a conflict check

Other Marks by Arena Pharmaceuticals GmbH

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company